Results 141 to 150 of about 25,211 (207)

Rigosertib as a potential therapeutic option for patients with recessive dystrophic epidermolysis bullosa squamous cell carcinoma. [PDF]

Br J Dermatol
Pritchard JJG, Inman GJ.
europepmc   +1 more source

[Dystrophic epidermolysis bullosa].

Vestnik dermatologii i venerologii, 1976
L M, Gol'dshteĭn, V B, Bakhtalovskiĭ, V E, Tkach   +2 more
openaire   +1 more source

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation. [PDF]

J Med Genet
Warshauer EM, Maier PA, Runfeldt G, Fuentes I, Escamez MJ, Valinotto L, Natale M, Manzur G, Illera N, Garcia M, Del Rio M, Mencia A, Holguin A, Larcher F, Hellenthal G, Brown AR, Consuegra L, Rivera C, Nogueiro I, Tang J, Oro A, Marinkovich P, Palisson F, Titeux M, Hovnanian AA, Sprecher E, Skorecki K, Norris D, Bruckner A, Kogut I, Bilousova G, Roop D.   +31 more
europepmc   +1 more source

Real-world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review. [PDF]

Acta Derm Venereol
Ling S, Dou X.
europepmc   +1 more source

Gynaeco-obstetrical follow-up of patients with dystrophic epidermolysis bullosa, a prospective study. [PDF]

Orphanet J Rare Dis
Fournier M, Bourrat E, Rapp J, Vexiau D, Trastour C, Chiaverini C.   +5 more
europepmc   +1 more source

Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial. [PDF]

Orphanet J Rare Dis
Biggs K, Ditta S, Bageta ML, Lopez-Balboa P, Glover R, Hutchence K, Papaioannou D, Julious S, Cooper C, Petrof G, Martinez AE.   +10 more
europepmc   +1 more source

Interdisciplinary Approach in Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa: Experience From the Dermatology Service and the Palliative Care and Complex Chronic Patient Team at Sant Joan de Déu Hospital (Barcelona, Spain). [PDF]

J Eval Clin Pract
Martínez-Ripoll JM, García-Domingo M, De la Fuente Robles YM.   +2 more
europepmc   +1 more source

A case of recessive dystrophic epidermolysis bullosa.

The Turkish journal of pediatrics, 1988
K Kocabay, H Güvenç, A Okten, S Bektaş   +3 more
openaire   +2 more sources

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study. [PDF]

JID Innov
Harrs C, Bolling M, van den Akker P, Koopman B, Horváth B, Diercks G, van Kempen L.   +6 more
europepmc   +1 more source